Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.43 |
| ▸ | LDHA | P00338 | 1/20 | 0.43 |
| ▸ | SRR | Q9GZT4 | 1/20 | 0.43 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.43 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.43 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.43 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 4/20 | 0.40 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.40 |
| ▸ | GLRA1 | P23415 | 1/20 | 0.40 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.40 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.40 |
| ▸ | ACE | P12821 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.35 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Thioglycolic Acid SCHEMBL59070 | 1.00 | — | — | |
| Thioglycolic Acid SCHEMBL10397517 | 1.00 | LMNA (0.43) | LMNALDHASRRALKBH5SUCNR1 | |
| Thioglycolic Acid SCHEMBL5534035 | 1.00 | — | — | |
| Thioglycolic Acid SCHEMBL9439584 | 1.00 | LMNA (0.43) | LMNALDHASRRALKBH5SUCNR1 | |
| Thioglycolic Acid SCHEMBL7033331 | 1.00 | — | — | |
| Thioglycolic Acid SCHEMBL16796586 | 1.00 | LMNA (0.43) | LMNALDHASRRALKBH5SUCNR1 | |
| Thioglycolic Acid SCHEMBL6897361 | 0.96 | — | — | |
| Thioglycolic Acid SCHEMBL10805371 | 0.96 | — | — | |
| Thioglycolic Acid SCHEMBL8404154 | 0.96 | — | — | |
| Thioglycolic Acid SCHEMBL21581908 | 0.96 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 334 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4590782-A1 | GAS-PHASE COMPOSITION FOR INHIBITING CORROSION EXPOSED TO CONDENSED WATER | Arkema France (FR) | 2025-07-30 | — | — | EP | claimed |
| EP-4441164-A1 | FOAMING COMPOSITION COMPATIBLE WITH STEEL FOR THE ASSISTED RECOVERY OF HYDROCARBONS | ARKEMA FRANCE (FR) | 2024-10-09 | — | — | EP | claimed |
| EP-3939469-B1 | HAIR HOLDER AND HAIR TREATMENT METHOD USING SAME | KAO CORP (JP) | 2024-09-11 | — | — | EP | claimed |
| WO-2024062191-A1 | GAS-PHASE COMPOSITION FOR INHIBITING CORROSION EXPOSED TO CONDENSED WATER | ARKEMA FRANCE (FR) | 2024-03-28 | — | — | WO | claimed |
| WO-2023099848-A1 | FOAMING COMPOSITION COMPATIBLE WITH STEEL FOR THE ASSISTED RECOVERY OF HYDROCARBONS | ARKEMA FRANCE (FR) | 2023-06-08 | — | — | WO | claimed |
| EP-3743270-B1 | CAST-MOLDING PROCESS FOR PRODUCING UV-ABSORBING CONTACT LENSES | ALCON INC (CH) | 2022-06-08 | — | — | EP | claimed |
| US-20220119569-A1 | Curable and Solvent Soluble Formulations and Methods of Making and Using Therof | POLY6 TECHNOLOGIES, INC. | 2022-04-21 | — | — | US | claimed |
| EP-3830318-A1 | ELECTROPLATING BATH FOR DEPOSITING A BLACK ALLOY, METHOD FOR THE ELECTROCHEMICAL DEPOSITION OF A BLACK ALLOY ON A SUBSTRATE, A BLACK ALLOY AND AN ARTICLE COATED WITH SUCH BLACK ALLOY | COVENTYA S.p.A. (IT) | 2021-06-09 | — | — | EP | claimed |
| US-20200062877-A1 | Curable and Solvent Soluble Formulations and Methods of Making and Using Therof | POLY6 TECHNOLOGIES, INC. | 2020-02-27 | — | — | US | claimed |
| WO-2020025448-A1 | ELECTROPLATING BATH FOR DEPOSITING A BLACK ALLOY, METHOD FOR THE ELECTROCHEMICAL DEPOSITION OF A BLACK ALLOY ON A SUBSTRATE, A BLACK ALLOY AND AN ARTICLE COATED WITH SUCH BLACK ALLOY | COVENTYA S.P.A. (IT) | 2020-02-06 | — | — | WO | claimed |
| US-20060115445-A1 | Compositions for treating keratin materials comprising electrophilic monomers and liquid crystal agents | L'OREAL S.A. (FR) | 2006-06-01 | — | — | US | claimed |
| US-20060083706-A1 | Haircare composition comprising at least one electrophilic monomer and micro- or nanoparticles of at least one solid lubricant | L'OREAL S.A. (FR) | 2006-04-20 | — | — | US | claimed |
| US-20060083762-A1 | Uses of compositions comprising electrophilic monomers and micro-particles or nanoparticles | L'OREAL S.A. (FR) | 2006-04-20 | — | — | US | claimed |
| US-20060078522-A1 | Composition for treating keratin materials comprising at least one electrophilic monomer and at least one salt | L'OREAL S.A. (FR) | 2006-04-13 | — | — | US | claimed |
| US-20020155081-A1 | Use of tris(hydroxymethyl) aminomethane in cold permanent waving processes | PROCTER & GAMBLE COMPANY, THE | 2002-10-24 | — | — | US | claimed |
| US-5520909-A | WATER SOLUBLE DISULFIDES AND MERCAPTAN REDUCING AGENTS FOR RELAXING HAIR | CONAIR CORPORATION (US) | 1996-05-28 | — | — | US | claimed |
| EP-0443741-B1 | Formulating device for cosmetically functional cosmetic products | REVLON CONSUMER PROD CORP (US) | 1995-06-14 | — | — | EP | claimed |
| US-4913900-A | AQUEOUS SOLUTION OF THIOGLYCOLATE AND DITHIODIGLYCOLATE SALTS, POLYHYDRIC MOISTURIZER, ALKALI; SUITABLE FOR DAMAGED HAIR | HELENE CURTIS, INC. (US) | 1990-04-03 | — | — | US | claimed |
| EP-0344653-A2 | Conditioning perm wave composition and method | Helene Curtis Industries, Inc. (US) | 1989-12-06 | — | — | EP | claimed |
| US-4572220-A | Composition for altering the configuration of hair | HELENE CURTIS INDUSTRIES, INC. (US) | 1986-02-25 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020155081-A1 | Use of tris(hydroxymethyl) aminomethane in cold permanent waving processes | MGMT, TET1, TET3 | LMNA 2446/4885LDHA 1946/4885SRR 1010/4885 |
| US-20060083762-A1 | Uses of compositions comprising electrophilic monomers and micro-particles or nanoparticles | KRT18, PRKDC, ACP1 | LMNA 916/4885LDHA 1702/4885SRR 4826/4885 |
| US-20060115445-A1 | Compositions for treating keratin materials comprising electrophilic monomers and liquid crystal agents | KRT18, PRKDC, CUTA | LMNA 953/4885LDHA 2636/4885SRR 3891/4885 |
| US-20060083706-A1 | Haircare composition comprising at least one electrophilic monomer and micro- or nanoparticles of at least one solid lubricant | MITF, CUTA, NACA | LMNA 2622/4885LDHA 755/4885SRR 2519/4885 |
| US-20060078522-A1 | Composition for treating keratin materials comprising at least one electrophilic monomer and at least one salt | KRT18, DSG1, DSC1 | LMNA 1665/4885LDHA 3988/4885SRR 2289/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.